Sanofi to sell 51% stake in Opella
Clayton Dubilier & Rice is nearing a deal to acquire control of Sanofi’s consumer health unit after the American buyout firm ...
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...
The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...
Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...
Analysts at Zacks Research decreased their Q4 2025 earnings estimates for Sanofi in a research note issued on Tuesday, ...
Weeks after penning a $110 million upfront deal with Orano Med for the global rights to a neuroendocrine tumor treatment, ...
Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...
Thursday’s agreement with Orano Med is the second in as many months. Sanofi in September made its first foray into the ...
Deal for consumer health arm has faced a political backlash over ceding controlling stake to American private equity group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback